Allianz Asset Management GmbH lowered its stake in Cooper Companies Inc (NYSE:COO) by 1.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 81,550 shares of the medical device company’s stock after selling 1,261 shares during the quarter. Allianz Asset Management GmbH owned approximately 0.17% of Cooper Companies worth $19,337,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently modified their holdings of COO. Janus Henderson Group PLC increased its stake in Cooper Companies by 558.5% in the 2nd quarter. Janus Henderson Group PLC now owns 2,175,791 shares of the medical device company’s stock worth $520,937,000 after purchasing an additional 1,845,368 shares in the last quarter. Koch Industries Inc. purchased a new position in Cooper Companies in the 2nd quarter worth about $312,000. Voya Investment Management LLC increased its stake in Cooper Companies by 973.4% in the 2nd quarter. Voya Investment Management LLC now owns 329,015 shares of the medical device company’s stock worth $78,773,000 after purchasing an additional 298,363 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. purchased a new position in Cooper Companies in the 2nd quarter worth about $71,050,000. Finally, William Blair Investment Management LLC purchased a new position in Cooper Companies in the 2nd quarter worth about $65,037,000. 96.79% of the stock is currently owned by hedge funds and other institutional investors.
COO has been the topic of a number of analyst reports. Jefferies Group set a $250.00 price target on Cooper Companies and gave the stock a “buy” rating in a research note on Thursday, August 17th. Zacks Investment Research cut Cooper Companies from a “buy” rating to a “hold” rating in a research note on Monday, August 21st. Cleveland Research reissued a “buy” rating on shares of Cooper Companies in a research note on Tuesday, August 22nd. Robert W. Baird restated a “buy” rating and set a $251.00 price objective on shares of Cooper Companies in a research report on Thursday, August 24th. Finally, KeyCorp restated a “hold” rating on shares of Cooper Companies in a research report on Monday, August 28th. Six research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. Cooper Companies has an average rating of “Buy” and an average price target of $259.70.
Shares of Cooper Companies Inc (COO) opened at $229.66 on Wednesday. The stock has a market capitalization of $11,182.45, a PE ratio of 23.50, a PEG ratio of 1.85 and a beta of 0.54. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.26 and a current ratio of 2.41. Cooper Companies Inc has a 1-year low of $172.83 and a 1-year high of $256.39.
Cooper Companies (NYSE:COO) last announced its quarterly earnings results on Thursday, December 7th. The medical device company reported $2.65 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $2.64 by $0.01. The business had revenue of $561.50 million during the quarter, compared to analyst estimates of $558.86 million. Cooper Companies had a return on equity of 16.02% and a net margin of 17.43%. The firm’s revenue was up 8.3% on a year-over-year basis. During the same period in the previous year, the company earned $2.28 EPS. sell-side analysts anticipate that Cooper Companies Inc will post 11.51 earnings per share for the current year.
In other news, Director Gary S. Petersmeyer sold 3,977 shares of Cooper Companies stock in a transaction dated Thursday, September 14th. The stock was sold at an average price of $244.94, for a total transaction of $974,126.38. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 1.60% of the stock is owned by insiders.
ILLEGAL ACTIVITY NOTICE: This report was originally posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this report on another website, it was illegally copied and reposted in violation of United States & international copyright and trademark law. The legal version of this report can be read at https://www.dispatchtribunal.com/2017/12/13/allianz-asset-management-gmbh-has-19-34-million-position-in-cooper-companies-inc-coo.html.
Cooper Companies Profile
The Cooper Companies, Inc is a global medical device company. The Company operates through two business units: CooperVision, Inc and CooperSurgical, Inc CooperVision offers soft contact lenses for the vision correction market. CooperVision develops, manufactures and markets a range of single-use, two-week and monthly contact lenses.
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cooper Companies Inc (NYSE:COO).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.